Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA ® (lopinavir and ritonavir) tablet, for oral use KALETRA ® (lopinavir and ritonavir) oral solution Initial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 14 days and older. Limitations of Use: Genotypic or phenotypic testing and/or treatment history should guide the use of KALETRA. The number of baseline lopinavir resistance-associated substitutions affects the virologic response to KALETRA [see Microbiology ( 12.4 )].
- generic_name
- lopinavir and ritonavir
- product_names
- Lopinavir and Ritonavir
- ndc
- 0074-3956, 0074-3956-46, 0074-4014, 0074-4014-12, 0074-3008, 0074-3008-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en